drugset / Trial / NCT06727838

Study on Drug Interaction of Metformin Tablets and HRS-7535 Tablets in Healthy Human

NCT06727838

Phase 1 Completed 18 enrolled Shandong Suncadia Medicine Co., Ltd.
NaSingle-groupOpen-labelTreatment

Summary

This study was a single-center, open, fixed-sequence, self-controlled trial design conducted in healthy subjects.

Timeline

Start
2024-12-31
Primary completion
2025-01-25
Completion
2025-01-25

Drugs

EvaluationDrugModalityDoseRoute
Subject HRS-7535 Small molecule
Subject Metformin Small molecule

Indications